‘Most’ cancer meds approved under FDA’s accelerated pathway couldn’t prove survival benefits after 5 years: study

‘Most’ cancer meds approved under FDA’s accelerated pathway couldn’t prove survival benefits after 5 years: study – FiercePharma
Read More